This post was originally published on this site An investigational Alzheimer’s treatment called bryostatin-1 failed to meet its primary goal — lesser evidence of dementia in people with more severe disease — in a Phase 2 clinical trial, Neurotrope, the company developing the therapy, announced in a press release. Bryostatin-1 is a molecule that activates…
This post was originally published on this site In a campaign featuring World Wrestling Entertainment (WWE) superstar and leukemia survivor Roman Reigns, video game publisher 2K is partnering with the Leukemia & Lymphoma Society to heighten awareness around blood cancers. The global partnership corresponds with 2K’s release of professional wrestling video game WWE 2K20, slated…
This post was originally published on this site The European Commission has approved a combination of Keytruda (pembrolizumab) with Inlyta (axitinib) for the first-line treatment of patients with advanced renal cell carcinoma (RCC). The approval is based on the results of the multi-center KEYNOTE-426 Phase 3 trial (NCT02853331), which involved 861 untreated patients with metastatic…
This post was originally published on this site The U.S. Federal Trade Commission (FTC) sent warning letters to three companies that sell cannabis-based products containing cannabidiol (CBD), cautioning them that making unsubstantiated claims about the health benefits of CBD could lead to legal action. The agency “urges the companies to review all claims made for…
This post was originally published on this site The imaging agent 68Ga-PSMA-11 has better detection rates than 18F-fluciclovine in men with recurrent prostate cancer who have already had radical surgery to remove the prostate and whose levels of prostate-specific antigen (PSA, a marker of disease) are very low, a study says. The findings of the…
This post was originally published on this site The University of New Mexico (UNM) Comprehensive Cancer Center and the New Mexico Alliance for Cancer Care have entered a collaboration with Personalis to use its cancer immunogenomics platform to identify which ovarian cancer patients respond to a new combination therapy — Lynparza (olaparib) plus the investigational…
This post was originally published on this site It seems like years have passed since I published a column. In reality, it’s been less than two months. But as we know, life can change pretty drastically over the course of a week, let alone a couple of months. I know that mine certainly has, and…
This post was originally published on this site A metastatic triple-negative breast cancer (TNBC) patient is being treated with CytoDyn’s investigational leronlimab (PRO 140) under an emergency investigational new drug (IND) application granted by the U.S. Food and Drug Administration, An emergency IND can be used by physicians to request permission to give an investigational…
This post was originally published on this site PTI-125, Cassava Sciences’ lead therapeutic candidate for the treatment of Alzheimer’s disease, significantly reduced the levels of disease biomarkers, brain inflammation, and neurodegeneration after 28 days of treatment, top-line data from a Phase 2 trial show. “Based on these encouraging biomarker results, this new treatment could be…
This post was originally published on this site In the time that it takes to read the first few paragraphs of this column, someone in the United States will develop Alzheimer’s disease. One person in the U.S. develops the illness every 65 seconds, according to a 2019 report. The Alzheimer’s Association indicates that just over…
